Successful desensitization of a patient with Fabry disease with agalsidase beta (Fabrazyme) anaphylaxis after omalizumab pretreatment
Ilona DuBuske, Kristin Schmidlin, Jonathan A. Bernstein
Topics & Concepts
GlobotriaosylceramideFabry diseaseMedicineEnzyme replacement therapyInduced pluripotent stem cellDiseaseInternal medicineChemistryBiochemistryEmbryonic stem cellGeneLysosomal Storage Disorders ResearchBiomedical Research and PathophysiologyTrypanosoma species research and implications